Page 3 - Neuroimmune Pharmacology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neuroimmune pharmacology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neuroimmune Pharmacology Today - Breaking & Trending Today

Retail weed could help Springs rebound, but disagreements stand fast


Colorado has sold over $10 billion in rec cannabis.
ShutterstockProfessional / Shutterstock.com
In the wake of last year’s economic shutdowns, five states have legalized recreational marijuana over the past four months. Colorado Springs, however, has yet to find a way to allow voters to decide whether recreational sale of the substance is right for the city. 
Colorado Springs, like most cities, suffered an economic blow last year. Commerce slowed to a crawl in all but a few industries. The unemployment rate rose to a record high of around 12 percent. The city of Colorado Springs instituted a hiring freeze and slashed operational budgets by 20 percent across departments, cutting more than $21 million from coffers. But while city government took a share of CARES Act funding the federal government distributed to the state last year — using it to plug holes in its budget for 2021 with $15.7 million in expenditure savings â� ....

United States , Rocky Mountain , El Paso County , Colorado Springs , Jacqueline Reed , Ashley Weber , Tom Scudder , Dirk Draper , John Suthers , While No Colorado Springs City Council , Centers For Disease , Sheriff Office , Colorado Department Of Revenue , El Paso County Sheriff Office , Colorado Springs Chamber , Institute Of Cannabis Research , El Paso County Intelligence Center , Colorado Springs Cannabis Association , Colorado Springs Mayor John , Colorado Department , Paso County Intelligence Center , Sheriff Bill Elder , Disease Control , Psychiatric Times , Neuroimmune Pharmacology , Chad Kinney ,

Rush researchers demonstrate success with new therapy for COVID-19


 E-Mail
A new therapy developed by researchers at Rush University Medical Center is showing success as a way to prevent COVID-19 symptoms in mice.
In a study published in the
Journal of Neuroimmune Pharmacology, mouse models with COVID-19 showed positive results when a small peptide was introduced nasally. The peptide proved effective in reducing fever, protecting the lungs, improving heart function and reversing cytokine storm a condition in which an infection triggers the immune system to flood the bloodstream with inflammatory proteins. The researchers also report success in preventing the disease from progression.
This could be a new approach to prevent SARS-CoV-2 infection and protect COVID-19 patients from breathing problems and cardiac issues, said Kalipada Pahan, PhD, the Floyd A. Davis Professor of Neurology at Rush and a Research Career Scientist at the Jesse Brown VA Medical Center. Understanding the mechanism is proving important to developing ef ....

United States , Malabendu Jana , Kalipada Pahan , Sumita Raha , Debashis Dutta , Ramak Mishra , Ramesh Kumar , Floyda Davis , Rush University Medical Center , Jesse Brown Va Medical Center , Research Career Scientist , Northwestern University , Neuroimmune Pharmacology , Jesse Brown , Medicine Health , Clinical Trials , Critical Care Emergency Medicine , Death Dying , Infectious Emerging Diseases , ஒன்றுபட்டது மாநிலங்களில் , கலிபாதா பஹான் , சுமிதா ரஹ , டெபாசிஸ் தத்தா , ரமேஷ் குமார் , அவசரம் பல்கலைக்கழகம் மருத்துவ மையம் , ஜெஸ்ஸி பழுப்பு வா மருத்துவ மையம் ,